DNA Script, a leader in the field of enzymatic de novo manufacturing of nucleic acids, today announced that Thomas Ybert, Ph.D, chief executive officer, will present at the GP-write Scientific Working Meeting on Tuesday, May 1 at 5:50 p.m. ET in Boston.
Ybert’s presentation will provide an overview of the company’s business and its industry-leading enzymatic synthesis platform. Ybert will also provide an update on the company’s recent progress.
For more information on the GP-write Scientific Working Meeting, please visit: http://engineeringbiologycenter.org/2018meeting/